about
Evaluation of the in vitro anti-atherogenic properties of lipid fractions of olive pomace, olive pomace enriched fish feed and gilthead sea bream (Sparus aurata) fed with olive pomace enriched fish feed.Evaluation of sensory and in vitro anti-thrombotic properties of traditional Greek yogurts derived from different types of milk.Lipids and cardiovascular disease: where does dietary intervention sit alongside statin therapy?Μetal Uptake by Sunflower (Helianthus annuus) Irrigated with Water Polluted with Chromium and Nickel.Phospholipids of Animal and Marine Origin: Structure, Function, and Anti-Inflammatory Properties.Dairy Fats and Cardiovascular Disease: Do We Really Need to be Concerned?Inflammation, not Cholesterol, Is a Cause of Chronic Disease.Structural Elucidation of Irish Organic Farmed Salmon (Salmo salar) Polar Lipids with Antithrombotic Activities.Changing the Irish dietary guidelines to incorporate the principles of the Mediterranean diet: proposing the MedÉire dietPlatelet aggregometry assay for evaluating the effects of platelet agonists and antiplatelet compounds on platelet functionIn Vitro Antithrombotic Properties of Salmon () Phospholipids in a Novel Food-Grade ExtractTotal, Neutral, and Polar Lipids of Brewing Ingredients, By-Products and Beer: Evaluation of Antithrombotic Activities.Bioprospecting for Antithrombotic Polar Lipids from Salmon, Herring, and Boarfish By-ProductsThe Effects of Oxidation on the Antithrombotic Properties of Tea Lipids Against PAF, Thrombin, Collagen, and ADPThe Potential Role of Dietary Platelet-Activating Factor Inhibitors in Cancer Prevention and TreatmentInflammation and cardiovascular disease: are marine phospholipids the answer?Forty Years Since the Structural Elucidation of Platelet-Activating Factor (PAF): Historical, Current, and Future Research Perspectives
P50
Q37303985-9EEF57AE-8847-4885-8A6A-5641B9309661Q37585986-086BBDF5-343E-43AE-8866-1CC3B1568242Q38816273-027B8AFE-6B6E-429C-ACA6-7B5050587D47Q41161263-08CA1E97-47FB-4E14-BC95-4651282848E9Q47840702-6679CF10-D096-44C7-999E-425DD98B1581Q51745937-FF28A30F-B4BC-42C3-AA15-C9C3CED2A823Q55446683-B47E539B-2B20-4F87-90A0-7CC1A76D5654Q55470328-540AE2E2-EEEE-4294-A084-FD24E043A888Q57465934-802087A7-AB2B-4713-AD88-F5FC43822684Q60933523-C019527D-76AD-4B32-A295-C2DB5667021DQ61813553-6589BFD4-42FE-464B-B7DB-FDF885312F6CQ64897489-BE46F55A-61A6-44B5-B07F-2D04570E4092Q90193519-1951DC9B-46A7-49F9-9F10-499133BF24FAQ90736662-435E9539-42B5-458E-AD13-C2A6BDC06C29Q91355276-488C4776-3FB5-469B-977C-384A80E6C1D8Q91751719-7901BDFF-5A46-4510-9E48-6DEAF4FC2B76Q91807444-365BFC2A-D3C8-4074-854F-4B0BE3210C05
P50
description
researcher ORCID ID = 0000-0001-8175-950X
@en
name
Ioannis Zabetakis
@ast
Ioannis Zabetakis
@en
Ioannis Zabetakis
@es
Ioannis Zabetakis
@nl
type
label
Ioannis Zabetakis
@ast
Ioannis Zabetakis
@en
Ioannis Zabetakis
@es
Ioannis Zabetakis
@nl
prefLabel
Ioannis Zabetakis
@ast
Ioannis Zabetakis
@en
Ioannis Zabetakis
@es
Ioannis Zabetakis
@nl
P31
P496
0000-0001-8175-950X